Source: Virtual Congress 2020 – Epidemiology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Polverino (Barcelona, Spain). Severity biomarkers once infected. Virtual Congress 2020 – Epidemiology

Member's Comments

No comment yet.

Related content which might interest you: Severity assessment tools in CAP Source: Eur Respir Monogr 2014; 63: 88-104 Year: 2014 CON: Severity scores are not useful Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?" Year: 2012 Severity of community-acquired-pneumonia in elderly. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Bronchiectasis Severity Index and FACED score correlation determinants Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index Source: International Congress 2019 – Bronchiectasis Year: 2019 Severity of OSA and Depression Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Vitamin D and Bronchiectasis Severity Index (BSI): A correlation Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Severity or risk of progression: what does serum ferritin really reflect in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Severity scores and management of community acquired pneumonia Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Severity of COPD is associated with leg atherosclerosis Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Severity scores do not accurately predict microbial aetiology in community-acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Severity distribution of COPD in primary care Source: Eur Respir J 2004; 24: Suppl. 48, 360s Year: 2004 Fatigue changes in IPF patients measured by the Fatigue Assessment Scale during antifibrotic treatment Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Community acquired pneumonia in patients with neuromuscular disorders. Severity assessment and outcome Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Severity and outcome of community acquired pneumonia in asthmatic patients Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Severity assessment in CAP according to in-hospital mortality in two populations Source: Eur Respir J 2005; 26: Suppl. 49, 259s Year: 2005 Severity of bronchial asthma: possible mechanisms Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models Year: 2007 Fatigue in IPF measured by the Fatigue Assessment Scale during antifibrotic treatment Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Severity distribution of physician-diagnosed COPD in the Netherlands Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021